HGH Somatropin (191 AA) refers to recombinant human growth hormone consisting of the full 191-amino acid sequence identical to pituitary-derived human growth hormone. Produced through recombinant DNA technology using expression systems, it represents the complete, biologically active form of GH, as opposed to truncated or modified analogues. Its 22-kDa molecular weight corresponds to the predominant isoform secreted by somatotroph cells.
Researchers have studied recombinant HGH extensively for its broad biological effects mediated through growth hormone receptors expressed in numerous tissues. Research has examined its stimulation of IGF-1 production in the liver, which mediates many of GH’s growth-promoting and metabolic effects. Studies have investigated its direct and IGF-1-mediated effects on protein synthesis, lipolysis, carbohydrate metabolism, and bone mineral density in preclinical models.
Preclinical research has employed recombinant HGH in models of GH deficiency to characterize the complete GH axis, studying changes in body composition, organ size, and metabolic parameters following restoration of GH signaling. Research has also examined GH’s interactions with insulin signaling pathways and its immunomodulatory properties. Its complete sequence fidelity makes it the reference compound for GH biology research.
For research use only. Not for human consumption. Iron Prairie Labs products are intended for qualified researchers and laboratory use only.
